Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review

被引：0
|
作者：
Y. Wan
F. Zeng
H. Tan
Y. Lu
Y. Zhang
L. Zhao
R. You
机构：
[1] Tongji Medical College,Department of Pharmacy, Union Hospital
[2] Huazhong University of Science and Technology,Department of Pharmacy
[3] Peking University Third Hospital,undefined
来源：
Osteoporosis International | 2022年 / 33卷
关键词：
Cost-effectiveness; Denosumab; Osteoporosis; Systematic review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：979 / 1015
页数：36
相关论文
共 50 条
  • [1] Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review
    Wan, Y.
    Zeng, F.
    Tan, H.
    Lu, Y.
    Zhang, Y.
    Zhao, L.
    You, R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2022, 33 (05) : 979 - 1015
  • [2] An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
    Nannan Li
    Dennis Cornelissen
    Stuart Silverman
    Daniel Pinto
    Lei Si
    Ingrid Kremer
    Sandrine Bours
    Robin de Bot
    Annelies Boonen
    Silvia Evers
    Joop van den Bergh
    Jean-Yves Reginster
    Mickaël Hiligsmann
    [J]. PharmacoEconomics, 2021, 39 : 181 - 209
  • [3] A Systematic Review of Cost-Effectiveness Analyses of Drugs for Postmenopausal Osteoporosis
    Mickaël Hiligsmann
    Silvia M. Evers
    Wafa Ben Sedrine
    John A. Kanis
    Bram Ramaekers
    Jean-Yves Reginster
    Stuart Silverman
    Caroline E. Wyers
    Annelies Boonen
    [J]. PharmacoEconomics, 2015, 33 : 205 - 224
  • [4] An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
    Li, Nannan
    Cornelissen, Dennis
    Silverman, Stuart
    Pinto, Daniel
    Si, Lei
    Kremer, Ingrid
    Bours, Sandrine
    de Bot, Robin
    Boonen, Annelies
    Evers, Silvia
    van den Bergh, Joop
    Reginster, Jean-Yves
    Hiligsmann, Mickael
    [J]. PHARMACOECONOMICS, 2021, 39 (02) : 181 - 209
  • [5] AN UPDATED SYSTEMATIC REVIEW OF COST-EFFECTIVENESS ANALYSES OF DRUGS FOR OSTEOPOROSIS
    Li, N.
    Cornelissen, D.
    Silverman, S.
    Pinto, D.
    Si, L.
    Kremer, I.
    Bours, S.
    Boonen, A.
    Evers, S.
    van den Bergh, J.
    Reginster, J. -Y.
    Hiligsmann, M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S491 - S491
  • [6] A Systematic Review of Cost-Effectiveness Analyses of Drugs for Postmenopausal Osteoporosis
    Hiligsmann, Mickael
    Evers, Silvia M.
    Ben Sedrine, Wafa
    Kanis, John A.
    Ramaekers, Bram
    Reginster, Jean-Yves
    Silverman, Stuart
    Wyers, Caroline E.
    Boonen, Annelies
    [J]. PHARMACOECONOMICS, 2015, 33 (03) : 205 - 224
  • [7] A systematic review of cost-effectiveness analyses of sequential treatment for osteoporosis
    Yu, Guangyi
    Tong, Suiju
    Liu, Jinyu
    Wan, Yuansheng
    Wan, Min
    Li, Sujuan
    You, Ruxu
    [J]. OSTEOPOROSIS INTERNATIONAL, 2023, 34 (04) : 641 - 658
  • [8] Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis
    Jonsson, B.
    Strom, O.
    Eisman, J. A.
    Papaioannou, A.
    Siris, E. S.
    Tosteson, A.
    Kanis, J. A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 (03) : 967 - 982
  • [9] Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis
    B. Jönsson
    O. Ström
    J. A. Eisman
    A. Papaioannou
    E. S. Siris
    A. Tosteson
    J. A. Kanis
    [J]. Osteoporosis International, 2011, 22 : 967 - 982
  • [10] Comment on: cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis
    B. Jönsson
    O. Ström
    J. A. Eisman
    A. Papaioannou
    E. S. Siris
    A. Tosteson
    J. A. Kanis
    [J]. Osteoporosis International, 2012, 23 : 2063 - 2065
12345